These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15729488)

  • 1. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
    Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.
    Tubau F; Liñares J; Rodríguez MD; Cercenado E; Aldea MJ; González-Romo F; Torroba L; Berdonces P; Plazas J; Aguilar L; Delgado A; García-Escribano N;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.
    Al-Naqshbandi AA; Chawsheen MA; Abdulqader HH
    J Infect Public Health; 2019; 12(3):330-336. PubMed ID: 30522892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Shimoyama N; Okujima H; Ito M; Kawaguchi H; Chiba H; Akizawa K; Katayama Y; Sugimoto K; Tashiro H; Kaimori M; Suwabe A; Obata R; Sugiyama T; Toyoshima S; Kato J; Kaku M; Kanemitsu K; Kunishima H; Okada J; Tazawa Y; Igari J; Oguri T; Watanabe K; Kobayashi Y; Uchida H; Totsuka K; Kon S; Nakamura K; Matsuda K; Hayashi I; Shiotani J; Shiotani J; Kanno H; Itoh A; Sumitomo M; Uchida T; Kawabata A; Oiwa C; Iwata M; Horii T; Ishigo S; Yoshimura T; Ichiyama S; Wada Y; Kimura S; Maesaki S; Itoh K; Noda Y; Yamashita T; Yamaguchi I; Kageyama F; Shaku E; Baba H; Inuzuka K; Okabe H; Tatewaki K; Moro K; Aihara M; Matsushima T; Niki Y; Kuw Abara M; Ikawa S; Tanaka M; Hinoda Y; Sugiura T; Kamioka M; Ono J; Takata T; Makino H; Murase M; Miyamoto H; Aizawa H; Honda J; Takii M; Nagasawa Z; Aoki Y; Hamazaki N; Tsutsui T; Nakagawa K; Iwata M; Hiramatsu K; Saikawa T; Yamane N; Kimoto H; Kotani T; Kageoka T; Hongo T; Masuda J; Miyanohara H; Tsujimura M; Yasujima M; Hayashi I
    Jpn J Antibiot; 2005 Feb; 58(1):17-44. PubMed ID: 15849869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002.
    Yamaguchi K; Ohno A;
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):135-43. PubMed ID: 15964502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
    Kuo LC; Yu CJ; Kuo ML; Chen WN; Chang CK; Lin HI; Chen CC; Lu MC; Lin CH; Hsieh WF; Chen LW; Chou Y; Huang MS; Lee CH; Chen SC; Thai SL; Chen PC; Chen CH; Tseng CC; Chen YS; Hsiue TR; Hsueh PR
    Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
    Dowzicky MJ; Chmelařová E
    J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Walkty A; Adam HJ; Laverdière M; Karlowsky JA; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):348-55. PubMed ID: 21353964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial epidemiology and antimicrobial resistance profiles of urinary specimens of the elderly.
    Gravey F; Loggia G; de La Blanchardière A; Cattoir V
    Med Mal Infect; 2017 Jun; 47(4):271-278. PubMed ID: 28408060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.